Publication | Closed Access

Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study

Neuroimaging BiomarkersNeuroimaging ModalityPsychiatryDisease ProgressionDopamine TransporterParkinson DiseaseSchizophreniaNeuropsychiatryNeuropharmacologyNeuroimagingNeurologyNeuroscienceDopamineMedicine